Gaea Asia Pacific Inc.
Sharing our experience for 27 years
GaeaOÜ / Gaea APAC Inc. is an agile full-service CRO in Phase I – III, IIT and Medical Device development in all of Europe , USA and Asia Pacific
Read more Agile full-service CRO Commissioned by Sponsors, Gaea Trial Acceleration identifies and addresses the issues at sites, that are blocking their enrollment.
Read more Trial Enrollment Accelerator The GaeaOÜ CEO will work in-house at a company to define the clinical strategy and execute it with the company’s choice of CRO Read more Clinical Trial Planning
Gaea was established (in United Kingdom) for defining clinical strategy, developing clinical plans and market assessments for hospital products, including OD
Initial work in HIT with bivalirudin: Nigel Goodman consulted for the Medicines Company (MEDCO) 1996-2003 and organised this trial (click here more detail)
Gaea entered trial enrolment acceleration for slow trials; working for sponsors, with sites to assess and define issues in recruitment / retention.
Gaea became an agile, full-service CRO
BREXIT ! Gaea moved to digital Estonia as GaeaOÜ: with clinical, operations, QA in Kiev and utilising providers in any geography, selected for trial needs
planning and execution of hospital trials, Phase I – III and IST, hard-to-recruit and complex.
All Europe, USA, Asia Pacific establish (2021)
History of Gaea
Experiences by Therapeutic Area
Experiences by study phase
Approximately 70% of clinical studies are phase III worldwide
Full-service via flexible providers so we are can meet sponsor needs – you don’t have to change to comply with our systems
Clinical Operations team cumulatively experienced in different therapeutic areas and countries of operations